High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/9450921

Download in:

View as

General Info

PMID
9450921